Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00023972
What this trial is testing

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo
Not applicableNot Yet RecruitingNCT05585554
What this trial is testing

Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy

Who this might be right for
Pancreatic Cancer
Viewray Inc. 267
Large-scale testing (Phase 3)Study completedNCT03941093
What this trial is testing

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Kyntra Bio 284
Testing effectiveness (Phase 2)Looking for participantsNCT05859750
What this trial is testing

AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Akeso 78
Early research (Phase 1)Study completedNCT05867121
What this trial is testing

Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma
Genentech, Inc. 102
Large-scale testing (Phase 3)Study completedNCT02694536
What this trial is testing

Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 80
Early research (Phase 1)Study completedNCT01908478
What this trial is testing

Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cedars-Sinai Medical Center 34
Early research (Phase 1)Active Not RecruitingNCT05704985
What this trial is testing

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Who this might be right for
CancerSolid TumorColorectal Cancer+6 more
DEKA Biosciences 39
Early research (Phase 1)Active Not RecruitingNCT05539430
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction CancerEsophageal Cancer+1 more
Legend Biotech USA Inc 56
Early research (Phase 1)UnknownNCT03435289
What this trial is testing

CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic Cancer
Atlantic Health System 24
Testing effectiveness (Phase 2)UnknownNCT00003780
What this trial is testing

Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Meyer Pharmaceuticals 150
Testing effectiveness (Phase 2)WithdrawnNCT04134468
What this trial is testing

MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209
What this trial is testing

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more
Seagen, a wholly owned subsidiary of Pfizer 350
Large-scale testing (Phase 3)UnknownNCT02311439
What this trial is testing

Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas

Who this might be right for
Cancer of Pancreas
Assiut University 1
Testing effectiveness (Phase 2)Study completedNCT00966706
What this trial is testing

Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 105
Testing effectiveness (Phase 2)Ended earlyNCT00550004
What this trial is testing

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine

Who this might be right for
Pancreatic Cancer
SciClone Pharmaceuticals 153
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Large-scale testing (Phase 3)Study completedNCT03377491
What this trial is testing

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

Who this might be right for
Pancreas Adenocarcinoma
NovoCure Ltd. 571
Not applicableLooking for participantsNCT05764720
What this trial is testing

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

Who this might be right for
Pancreatic Cancer
Varian, a Siemens Healthineers Company 134
Not applicableWithdrawnNCT01795274
What this trial is testing

Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial

Who this might be right for
Locally Advanced Pancreatic Cancer
University Hospital Heidelberg
Next Page